| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |